Intriguingly, animal studies have shown that dopamine levels are decreased in rat models expressing epilepsy linked Scn1A mutations (Ohmori et al., 2014), providing a functional link between the overexpression of Scn1A and reduced dopamine levels in the NPRL2 nKO model. Here, SCN1A is linked to epilepsy.